ash 2019: ixazomib as maintenance therapy results | dr. ravi vij
Published 4 years ago • 225 plays • Length 3:47Download video MP4
Download video MP3
Similar videos
-
2:55
ash 2018: ixazomib rev dex consolidation therapy after transplant with ixazomib or rev maintenance
-
2:55
ash 2019: the optimum trial | dr. martin kaiser
-
58:48
best of ash 2019
-
3:32
ash 2019: double hit myeloma | dr. martin kaiser
-
2:31
asco/eha 2024 myeloma highlights- imroz, dreamm-7, dreamm-8 | joshua richter, md | eha 2024
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
2:38
how close is a cure for multiple myeloma?
-
6:54
physical therapy with myeloma
-
3:11
ash 2019: 3d tumor modeling — mcri update | dr. cesar rodriguez
-
2:24
ash 2019: the candor trial (late breaking abstract) | dr. saad usmani
-
3:10
clinical trials: two myeloma transplant trials, ravi vij, md
-
0:41
ravi vij, md, discusses current maintenance regimens for multiple myeloma
-
3:15
ash 2019: bcma car-t, immunotherapy and developing a myeloma cure | dr. siddhartha ganguly
-
1:23
standards of care for myeloma patients | ash 2020
-
1:04
dr. kumar on ixazomib combo for multiple myeloma treatment
-
2:06
ash 2019: novel therapies and a trial using mrd as a surrogate endpoint | dr. nina shah
-
1:29
ash 2019: researching why some myeloma cells cause bone lesions | dr. jens hillengass
-
2:38
ash 2019: research updates | dr. saad usmani
-
3:22
updated safety and efficacy results of abbv-383 | ravi vij, md, mba | ash 2023
-
2:01
ash 2019: high-risk smoldering myeloma treatment research | dr. irene ghobrial
-
1:56
dr. kumar discusses study of ixazomib in multiple myeloma